Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:PRE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumePREPrenetics Global$12.39+3.3%$8.38$3.09▼$12.59$155.82M0.1582,654 shs285,227 shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformancePREPrenetics Global+3.25%+26.69%+70.90%+54.59%+184.17%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumePREPrenetics Global$12.39+3.3%$8.38$3.09▼$12.59$155.82M0.1582,654 shs285,227 shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformancePREPrenetics Global+3.25%+26.69%+70.90%+54.59%+184.17%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PricePREPrenetics Global 3.00Buy$9.00-27.36% DownsideCurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookPREPrenetics Global$30.62M5.25N/AN/A$13.20 per share0.94Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DatePREPrenetics Global-$46.30M-$3.99N/AN/AN/A-87.92%-31.05%-24.16%10/6/2025 (Estimated)Latest SOLG, ADT1, PRE, and GFM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails10/6/2025N/APREPrenetics Global-$0.71N/AN/AN/A$21.70 millionN/A9/12/2025Q2 2025PREPrenetics GlobalN/A-$0.82N/A-$0.94N/A$17.68 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthPREPrenetics GlobalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioPREPrenetics GlobalN/A2.162.06Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipPREPrenetics Global25.01%Insider OwnershipCompanyInsider OwnershipPREPrenetics GlobalN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionablePREPrenetics Global112.98 millionN/ANot OptionableSOLG, ADT1, PRE, and GFM HeadlinesRecent News About These CompaniesEquities Analysts Offer Predictions for PRE FY2025 EarningsSeptember 20 at 6:37 AM | marketbeat.comShort Interest in Prenetics Global Limited (NASDAQ:PRE) Expands By 52.1%September 16, 2025 | marketbeat.comPrenetics Global (NASDAQ:PRE) Posts Quarterly Earnings ResultsSeptember 14, 2025 | marketbeat.comPrenetics Global Second Quarter 2025 Earnings: Misses ExpectationsSeptember 13, 2025 | finance.yahoo.comPrenetics Announces Second Quarter 2025 Financial Results with IM8 on Track to Achieve $100M Annual Recurring Revenue by Year’s EndSeptember 13, 2025 | taiwannews.com.twTPrenetics Global Limited: Prenetics Announces Second Quarter 2025 Financial Results with IM8 on Track to Achieve $100M Annual Recurring Revenue by Year's EndSeptember 12, 2025 | finanznachrichten.dePrenetics Global Rises After Narrowing Full-Year Revenue GuidanceSeptember 12, 2025 | marketwatch.comPrenetics Reports Strong Q2 2025 Growth and Strategic InitiativesSeptember 12, 2025 | tipranks.comPrenetics Announces Second Quarter 2025 Financial Results with IM8 on Track to Achieve $100M Annual Recurring Revenue by Year's EndSeptember 12, 2025 | globenewswire.comPrenetics’ IM8 Congratulates Global Ambassador and Shareholder - World No. 1 Aryna Sabalenka on Defending Her US Open ChampionshipSeptember 8, 2025 | markets.businessinsider.comAryna Sabalenka Makes History by Defending US Open Title; IM8 Experiences Rapid Growth with Viral Marketing CampaignSeptember 8, 2025 | quiverquant.comQBeckham's IM8 AI Ad Promotes 'The Best'September 3, 2025 | mediapost.comMPrenetics Global Divests ACT Genomics Stake and Invests in BitcoinAugust 22, 2025 | tipranks.comPrenetics Approves Major Share Capital Increase at August 2025 MeetingAugust 1, 2025 | tipranks.comPrenetics Global Limited (PRE) Earnings Surprise Summary (EPS ...July 25, 2025 | seekingalpha.comPrenetics Global Limited Adopts Bitcoin Treasury Strategy Amidst Market VolatilityJuly 17, 2025 | tipranks.comPRE Prenetics Global Limited - Seeking AlphaJuly 9, 2025 | seekingalpha.comPrenetics Global Limited (PRE) - Yahoo FinanceJune 30, 2025 | finance.yahoo.comAryna Sabalenka Adds Her Muscle to IM8 as Ambassador & ShareholderJune 30, 2025 | msn.comAryna Sabalenka Becomes First Current Athlete Shareholder in Prenetics' IM8 Supplements BrandJune 26, 2025 | quiverquant.comQWorld No. 1 Tennis Star Aryna Sabalenka Joins Prenetics' IM8 Health as Global Ambassador and ShareholderJune 26, 2025 | globenewswire.comMedia Sentiment Over Time Top HeadlinesView All HeadlinesNIO Just Got Its Second Upgrade of the Month, and It’s BigBy Sam Quirke | August 28, 2025Eyes on the Sky: AST SpaceMobile Prepares for Commercial LaunchBy Jordan Chussler | September 8, 2025Intel's Silent Comeback: 3 Pillars the Market Is OverlookingBy Jeffrey Neal Johnson | September 12, 20253 Tariff-Proof Retailers Making New All-time HighsBy Dan Schmidt | September 1, 20253 Gold ETFs That Could Surge If the Fed Cuts Rates This MonthBy Jordan Chussler | September 1, 2025SOLG, ADT1, PRE, and GFM Company DescriptionsPrenetics Global NASDAQ:PRE$12.39 +0.39 (+3.25%) Closing price 09/22/2025 04:00 PM EasternExtended Trading$12.38 -0.02 (-0.12%) As of 06:33 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 High-Yields at 52-Week Lows: Buy, Sell, or Hold Advance Auto Parts is A Great Risk/Reward Play If EPS Delivers 3 Small Caps That Insiders Are Buying Banks Boost Gold Forecasts: One Sees +30% Bull-Case Potential These 3 Stocks Boosting Buybacks Have Rallying Potential GameStop Partying Like It’s 2021: What’s Behind Its 2025 Rebound? Hims & Hers Stock Pushes to Highs on Healthcare Rate Cut Frenzy Why Robinhood Stock Is Soaring—and What Comes Next Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
